Keith Wheatley

Research Projects

  1. PARC: A Phase I / II study evaluating the activity of Pegylated recombinant human Arginase (BCT-100) in RElapsed/refractory Cancers of childhood

    Francis Mussai, Andrew Beggs, , Keith Wheatley, Carmela De Santo, Pamela Kearns & Daniel Slade

    BIO-CANCER TREATMENT INTERNATIONAL LTD, INNOVATIVE THERAPIES FOR CHILDREN WITH CANCER (ITCC), Cancer Research UK

    1/12/1730/11/21

    Project: Research

Previous 1 2 3 4 5 6 7 Next